Innovation Pharmaceuticals Signs Deal to Use Tablet Technology for Oral Brilacidin Treatment
News
Innovation Pharmaceuticals has signed an agreement to use OralogiK — an advanced tablet-coating technology patented by BDD Pharma — to develop tablets for targeted oral delivery of Brilacidin for treating ... Read more